Capital Mãe

计划入组 446 人

Restore Myocardial Function With CorMatrix® ECM® Particulate (P-ECM)

计划入组 9 人 · 首次发布于 2014 年 5 月 15 日

CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without ECM

计划入组 44 人 · 首次发布于 2012 年 2 月 20 日

PAD4 inhibitors(Capital Medical University)

IGC-AD1

Ad-TD-nsIL12(Capital Medical University)

Platinum Capital Ltd

BDE CAPITAL PTY LTD

Australia

St George Street Capital Ltd.

United Kingdom

Electra Battery Materials Secures $30 Million Financing for North America's First Cobalt Sulfate Refinery

FDA Approves IDE for ECM Therapeutics' Novel Hydrogel Treatment for Anorectal Fistulas

Engitix Secures €21 Million Series A Extension to Advance ECM-Targeted Cancer and Fibrosis Therapies